Peginterferon alpha-based therapy for chronic hepatitis B focusing on HBsAg clearance or seroconversion: a meta-analysis of controlled clinical trials.

Peginterferon alpha-based therapy for chronic hepatitis B focusing on HBsAg clearance or seroconversion: a meta-analysis of controlled clinical trials.

Item
http://www.wikidata.org/entity/Q33926126
Current and future directions for treating hepatitis B virus infectionChronic hepatitis B in 2014: great therapeutic progress, large diagnostic deficit.Mutations of pre-core and basal core promoter before and after hepatitis B e antigen seroconversionCONSORT: Effects of adding adefovirdipivoxil to peginterferon alfa-2a at different time points on HBeAg-positivepatients: A prospective, randomized study.Antiviral treatment to prevent chronic hepatitis B or C-related hepatocellular carcinoma.Standard and pegylated interferon therapy of HDV infection: A systematic review and meta- analysis.Hepatitis B virus surface antigen seroconversion in HIV-infected individual after pegylated interferon-alpha treatment: a case report.Persistent Loss of Hepatitis B Virus Markers in Serum without Cellular Immunity by Combination of Peginterferon and Entecavir Therapy in Humanized Mice.Combination therapy with pegylated interferon alpha-2b and adefovir dipivoxil in HBeAg-positive chronic hepatitis B versus interferon alone: a prospective, randomized study.Kinetics of hepatitis B surface antigen loss in patients with HBeAg-positive chronic hepatitis B treated with tenofovir disoproxil fumarate.Relationship between adhesion molecules and virological response to pegylated interferon-alpha-2a treatment in patients with chronic hepatitis B: A pilot study.Sustained efficacy of adefovir add-on therapy in chronic hepatitis B patient with a poor virological response to peginterferon alfa.Influence of Vitamin D Receptor Gene Polymorphisms on Response to Pegylated Interferon in Chronic Hepatitis B Egyptian Patients.
P2860

Peginterferon alpha-based therapy for chronic hepatitis B focusing on HBsAg clearance or seroconversion: a meta-analysis of controlled clinical trials.

Item
http://www.wikidata.org/entity/Q33926126
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Peginterferon alpha-based ther ...... of controlled clinical trials.
@ast
Peginterferon alpha-based ther ...... of controlled clinical trials.
@en
type
label
Peginterferon alpha-based ther ...... of controlled clinical trials.
@ast
Peginterferon alpha-based ther ...... of controlled clinical trials.
@en
prefLabel
Peginterferon alpha-based ther ...... of controlled clinical trials.
@ast
Peginterferon alpha-based ther ...... of controlled clinical trials.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P478
P577
P5875
P6179
P698
P921
P932
P356
P1433
P1476
Peginterferon alpha-based ther ...... of controlled clinical trials.
@en
P2093
P2860
P2888
P304
P31
P356
P478
P577
P5875
P6179
P698
P921
P932